{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:46:51Z","timestamp":1793371611317,"version":"4.5.0"},"reference-count":38,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,10,15]]},"DOI":"10.2169\/internalmedicine.6661-25","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:09:27Z","timestamp":1792015767000},"page":"2750-2757","source":"Crossref","is-referenced-by-count":1,"title":["Eosinophilic Gastroenteritis during Tocilizumab Treatment for Castleman Disease"],"prefix":"10.2169","volume":"65","author":[{"given":"Hiromitsu","family":"Kaneko","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Hayashino","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Japan"},{"name":"Department of Hematology and Oncology, Okayama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeru","family":"Aasano","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoka","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Japanese Red Cross Society Himeji Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiko","family":"Hotta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Japanese Red Cross Society Himeji Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takashima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Japanese Red Cross Society Himeji Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Fajgenbaum DC, Uldrick TS, Bagg A, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease. Blood 129: 1646-1657, 2017.","DOI":"10.1182\/blood-2016-10-746933"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. van Rhee F, Voorhees P, Dispenzieri A, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood 132: 2115-2124, 2018.","DOI":"10.1182\/blood-2018-07-862334"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood 135: 1353-1364, 2020.","DOI":"10.1182\/blood.2019000931"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106: 2627-2632, 2005.","DOI":"10.1182\/blood-2004-12-4602"},{"key":"5","unstructured":"5. US Food and Drug Administration. ACTEMRA (tocilizumab) [prescribing information] [Internet]. [cited 2025 Sep 3]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/125276s144,125472s056lbl.pdf"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Morrisroe K, Wong M. Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritis. Rheumatology (Oxford) 54: 2113-2114, 2015.","DOI":"10.1093\/rheumatology\/kev275"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zuelgaray E, Domont F, Peiffer-Smadja N, Saadoun D, Cacoub P. Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms syndrome in adult-onset still disease. Ann Intern Med 167: 141-142, 2017.","DOI":"10.7326\/L16-0592"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Uppal V, Kreiger P, Kutsch E. Eosinophilic gastroenteritis and colitis: comprehensive review. Clin Rev Allergy Immunol 50: 175-188, 2016.","DOI":"10.1007\/s12016-015-8489-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sunkara T, Rawla P, Yarlagadda KS, Gaduputi V. Eosinophilic gastroenteritis: diagnosis and clinical perspectives. Clin Exp Gastroenterol 12: 239-253, 2019.","DOI":"10.2147\/CEG.S173130"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zhang L, Duan L, Ding S, et al. Eosinophilic gastroenteritis: clinical manifestations and morphological characteristics, a retrospective study of 42 patients. Scand J Gastroenterol 46: 1074-1080, 2011.","DOI":"10.3109\/00365521.2011.579998"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 31: 54-58, 1990.","DOI":"10.1136\/gut.31.1.54"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13. Mogilevski T, Nickless D, Hume S. \u0392-lactam-associated eosinophilic colitis. BMJ Case Rep 2015: bcr2014206964, 2015.","DOI":"10.1136\/bcr-2014-206964"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. Kinoshita Y, Oouchi S, Yahata S. Eosinophilic gastrointestinal diseases: pathogenesis, diagnosis, and treatment. Intern Med 61: 1-10, 2022.","DOI":"10.2169\/internalmedicine.8417-21"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Fujimoto S, Koga T, Kawakami A, et al. Tentative diagnostic criteria and disease severity classification for Castleman disease: a report of the research group on Castleman disease in Japan. Mod Rheumatol 28: 161-167, 2018.","DOI":"10.1080\/14397595.2017.1366093"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Sunkara T, Rawla P, Yarlagadda KS, Gaduputi V. Eosinophilic gastroenteritis: diagnosis and clinical perspectives. Clin Exp Gastroenterol 12: 239-253, 2019.","DOI":"10.2147\/CEG.S173130"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Lwin T, Melton SD, Genta RM. Eosinophilic gastritis: histopathological characterization and quantification of the normal gastric eosinophil content. Mod Pathol 24: 556-563, 2011.","DOI":"10.1038\/modpathol.2010.221"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18. Hentschel F, Jansen AF, G\u00fcnther M, Pauli R, L\u00fcth S. Eosinophil counts in mucosal biopsies of the ileum and colon: interobserver variance affects diagnostic accuracy. Patholog Res Int 2018: 2638258, 2018.","DOI":"10.1155\/2018\/2638258"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. Zhang M, Li Y. Eosinophilic gastroenteritis: a state-of-the-art review: eosinophilic gastroenteritis. J Gastroenterol Hepatol 32: 64-72, 2017.","DOI":"10.1111\/jgh.13463"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20. Hafidh K, Kazmi T, Alhaj A, Nazir Z. Carbimazole-induced eosinophilic gastroenteritis in a young female with abdominal pain and ascites: a case report. J Med Case Rep 18: 559, 2024.","DOI":"10.1186\/s13256-024-04866-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Barak N, Hart J, Sitrin MD. Enalapril-induced eosinophilic gastroenteritis. J Clin Gastroenterol 33: 157-158, 2001.","DOI":"10.1097\/00004836-200108000-00014"},{"key":"21","doi-asserted-by":"publisher","unstructured":"22. Nakahama H, Nakamura H, Kuribayashi K, et al. Two cases of eosinophilic gastroenteritis associated with analgesic-induced bronchial asthma. Respirology 3: 95-97, 1998.","DOI":"10.1111\/j.1440-1843.1998.tb00103.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Lin R, Ye K, Hong M, Li J, Zhang Z, Zhang X. Eosinophilic gastroenteritis in an elderly men associated with antibiotic use post maxillofacial space infection: a case report. Front Med (Lausanne) 11: 1370674, 2024.","DOI":"10.3389\/fmed.2024.1370674"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24. Hayashida S, Sato S, Shimada Y, et al. Eosinophilic gastroenteritis in an ulcerative colitis patient during treatment with tumor necrosis factor-alpha antagonist. Intern Med 59: 1977-1981, 2020.","DOI":"10.2169\/internalmedicine.4554-20"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Tsuji A, Hiramatsu K, Namikawa S, et al. A rare case of eosinophilic gastritis induced by nivolumab therapy for metastatic melanoma. Clin J Gastroenterol 15: 876-880, 2022.","DOI":"10.1007\/s12328-022-01680-y"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Parsi M, Daniel C. Lamotrigine-induced DRESS syndrome manifesting as &apos;eosinophilic colitis&apos;: an uncommon presentation of a very uncommon condition. Cureus 12: e7570, 2020.","DOI":"10.7759\/cureus.7570"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27. Nicol\u00e1s-S\u00e1nchez FJ, Garreta-Messegue J, Gallel-Vicente P, Gort-Orom\u00ed A, Soler-Rosell T, Sarrat-Nuevo RM. Eosinophilic colitis associated with letrozole. Gastroenterol Hepatol 34: 129-130, 2011.","DOI":"10.1016\/j.gastrohep.2010.10.015"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28. Shouval R, Duffield A, Gocke C, Lee L, Brodsky RA. Pentostatin-induced hypereosinophilia with eosinophilic gastroenteritis. Leuk Lymphoma 51: 1567-1569, 2010.","DOI":"10.3109\/10428194.2010.486879"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29. Horino T, Ohnishi H, Komori M, Terada Y. Hypereosinophilic syndrome presenting as eosinophilic gastroenteritis exacerbated by clopidogrel bisulphate. Rom J Intern Med 61: 216-221, 2023.","DOI":"10.2478\/rjim-2023-0022"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30. Lee JY, Lee JH. mRNA COVID-19 vaccine-associated subserosal eosinophilic gastroenteritis: a case report. J Korean Med Sci 37: e233, 2022.","DOI":"10.3346\/jkms.2022.37.e233"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31. Karmacharya R, Mino M, Pirl WF. Clozapine-induced eosinophilic colitis. Am J Psychiatry 162: 1386-1387, 2005.","DOI":"10.1176\/appi.ajp.162.7.1386-a"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32. Anttila VJ, Valtonen M. Carbamazepine-induced eosinophilic colitis. Epilepsia 33: 119-121, 1992.","DOI":"10.1111\/j.1528-1157.1992.tb02293.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33. Bridges AJ, Marshall JB, Diaz-Arias AA. Acute eosinophilic colitis and hypersensitivity reaction associated with naproxen therapy. Am J Med 89: 526-527, 1990.","DOI":"10.1016\/0002-9343(90)90386-R"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34. Nizam A, Gaballah S, Ozaibi LA, Raman LG. Isotretinoin as a possible cause for eosinophilic esophagitis and eosinophilic gastroenteritis: a case report. Cureus 15: e42649, 2023.","DOI":"10.7759\/cureus.42649"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35. Ishido K, Tanabe S, Higuchi K, et al. Eosinophilic gastroenteritis associated with giant folds. Dig Endosc 22: 312-315, 2010.","DOI":"10.1111\/j.1443-1661.2010.01012.x"},{"key":"35","unstructured":"36. Spencer S, K\u00f6stel Bal S, Egner W, et al. Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses. J Exp Med 216: 1986-1998, 2019."},{"key":"36","doi-asserted-by":"crossref","unstructured":"37. Desmet SJ, De Bosscher K. Glucocorticoid receptors: finding the middle ground. J Clin Invest 127: 1136-1145, 2017.","DOI":"10.1172\/JCI88886"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38. Barak N, Hart J, Sitrin MD. Enalapril-induced eosinophilic gastroenteritis. J Clin Gastroenterol 33: 157-158, 2001.","DOI":"10.1097\/00004836-200108000-00014"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39. Ishido K, Tanabe S, Higuchi K, et al. Eosinophilic gastroenteritis associated with giant folds: eosinophilic gastroenteritis. Dig Endosc 22: 312-315, 2010.","DOI":"10.1111\/j.1443-1661.2010.01012.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/20\/65_6661-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:16:19Z","timestamp":1792210579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/20\/65_6661-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":38,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6661-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"article-number":"6661-25"}}